Centre for Evolution and Cancer, The Institute of Cancer Research, London, SM2 5NG, UK.
Department of Cell and Developmental Biology, University College London, London, UK.
Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):95-100. doi: 10.1016/j.bbcan.2016.12.003. Epub 2017 Jan 7.
The cancer genome is shaped by three components of the evolutionary process: mutation, selection and drift. While many studies have focused on the first two components, the role of drift in cancer evolution has received little attention. Drift occurs when all individuals in the population have the same likelihood of producing surviving offspring, and so by definition a drifting population is one that is evolving neutrally. Here we focus on how neutral evolution is manifested in the cancer genome. We discuss how neutral passenger mutations provide a magnifying glass that reveals the evolutionary dynamics underpinning cancer development, and outline how statistical inference can be used to quantify these dynamics from sequencing data. We argue that only after we understand the impact of neutral drift on the genome can we begin to make full sense of clonal selection. This article is part of a Special Issue entitled: Evolutionary principles - heterogeneity in cancer? Edited by Dr. Robert A. Gatenby.
突变、选择和漂变。虽然许多研究都集中在前两个组成部分,但漂变在癌症进化中的作用却很少受到关注。当种群中的所有个体产生存活后代的可能性相同时,就会发生漂变,因此,从定义上讲,漂变种群就是中性进化的种群。在这里,我们关注的是中性进化如何在癌症基因组中表现出来。我们讨论了中性的乘客突变如何提供一个放大镜,揭示了癌症发展的进化动态,并概述了如何使用统计推断从测序数据中量化这些动态。我们认为,只有在了解了中性漂变对基因组的影响之后,我们才能开始充分理解克隆选择。本文是一个特刊的一部分,该特刊题为:进化原理-癌症中的异质性?由罗伯特·A·盖滕比博士编辑。